Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion type Assertion NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_head.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion description "[The evidences of our investigations show that MLH1 and MSH2 gene mutations have an equivalent etiopathological role both for Lynch syndrome and for MTS; hence, we propose a broadened clinical criteria for definition of Lynch syndrome that will include sebaceous adenoma, carcinoma, and keratoacanthoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion evidence source_evidence_literature NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion SIO_000772 16826164 NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion wasDerivedFrom befree-2016 NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.
- NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_assertion wasGeneratedBy ECO_0000203 NP558722.RA_CUgEpKOwaEVZRCdejV1BElnJpbFrOY3AbRwtYRFMQU130_provenance.